Why the Rich Want to Live Forever — with Kara Swisher

In this episode, host Kara Swisher explores why today’s wealthiest tech figures are betting heavily on longevity. She outlines how Jeff Bezos, Larry Ellison, Sam Altman, Mark Zuckerberg and others are funneling billions into anti‑aging institutes, gene‑editing labs, and biotech startups. Their investments signal a shift from traditional venture capital to a market that treats age‑related disease as the next frontier, reflecting both personal ambition and the massive economic upside of extending healthy lifespan.

Swisher separates the hype from the hard science, noting that while trends like intermittent fasting, peptide cocktails, and celebrity‑driven Soylent diets dominate social feeds, genuine breakthroughs are emerging. GLP‑1 agonists, mRNA vaccine platforms, and CRISPR‑based therapies offer measurable health gains, whereas many “quick‑fix” regimens remain unproven. The conversation also uncovers personal motivations—mid‑life crises, the desire for sexual vitality, and the pursuit of a youthful image—driving billionaires to experiment with human growth hormone, creatine stacks, and even steroids.

The episode concludes with a broader look at societal impact. As public scrutiny intensifies, the gap between wealthy bio‑hackers and everyday consumers widens, raising ethical questions about access and equity. Swisher urges listeners to evaluate claims critically, focusing on peer‑reviewed data rather than viral hype. The dialogue underscores that while longevity research holds transformative promise, discerning real science from fad is essential for informed decision‑making in both personal health and investment strategy.